Double Bond Pharmaceutical International AB

Double Bond Pharmaceuticals utvecklar en ny generation av läkemedel inom cancer, infektion och autoimmuna sjukdomar.

Bolag	Emissionsbelopp	Teckningsperiod
RE Double Bond Pharmaceutical International AB	1 MSEK	22 maj 2026
RE Double Bond Pharmaceutical International AB	1 MSEK	16 dec. 2025
FE Double Bond Pharmaceutical International AB	15,7 MSEK	17 juni 2025 - 1 juli 2025
NY Double Bond Pharmaceutical International AB	-	20 feb. 2024
NY Double Bond Pharmaceutical International AB	-	22 maj 2023
NY Double Bond Pharmaceutical International AB	-	6 feb. 2023
NY Double Bond Pharmaceutical International AB	-	22 apr. 2022
NY Double Bond Pharmaceutical International AB	-	20 sep. 2021
NY Double Bond Pharmaceutical International AB	-	14 maj 2021
NY Double Bond Pharmaceutical International AB	-	3 mars 2020
NY Double Bond Pharmaceutical International AB	-	26 feb. 2020
NY Double Bond Pharmaceutical International AB	-	26 apr. 2019
NY Double Bond Pharmaceutical International AB	-	21 jan. 2019
NY Double Bond Pharmaceutical International AB	-	20 dec. 2018
NY Double Bond Pharmaceutical International AB	-	24 sep. 2018
NY Double Bond Pharmaceutical International AB	-	5 apr. 2018
NY Double Bond Pharmaceutical International AB	-	21 dec. 2017
NY Double Bond Pharmaceutical International AB	-	9 nov. 2017
NY Double Bond Pharmaceutical International AB	-	26 apr. 2017
NY Double Bond Pharmaceutical International AB	-	22 dec. 2016
NY Double Bond Pharmaceutical International AB	-	7 juni 2016
NY Double Bond Pharmaceutical International AB	-	30 juni 2015

Företagsnamn

Organisationsnummer

556991-6082

Address

Virdings allé 32 B 1tr, Uppsala 754 50

Få de senaste nyheterna om börsnoteringar och nyemissioner direkt i din inkorg.